mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
importazole |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
MLN2238 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
silmitasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.6 |
mRNA |
BRD-K84807411 |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.6 |
mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
NSC632839 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |